<DOC>
	<DOCNO>NCT00211107</DOCNO>
	<brief_summary>The primary purpose study demonstrate dapoxetine prolong intravaginal ejaculatory latency time ( IELT ) compare placebo men premature ejaculation ( PE ) .</brief_summary>
	<brief_title>A Study Effectiveness Safety Dapoxetine Treatment Men With Premature Ejaculation .</brief_title>
	<detailed_description>One form male sexual dysfunction premature ejaculation ( PE ) , also refer rapid ejaculation ( RE ) . An objective measurement PE clinical study intravaginal ejaculatory latency time ( IELT ) . This randomized , double-blind study men PE . The study consist 2 phase : pre-randomization phase ( screen visit 2-week baseline period ) ; 12-week double-blind treatment phase patient receive dapoxetine one two dosage , placebo , use `` as-needed '' basis . The total duration study approximately 14 week . Patients partner expect attempt sexual intercourse least 4 time baseline period least 6 time month treatment phase . Assessments effectiveness include average Intravaginal Ejaculatory Latency time ( IELT ) , measure stopwatch , sexual intercourse treatment period ( 12 week ) ; control ejaculation , satisfaction sexual intercourse , severity symptom , base question ask monthly interval treatment phase . Safety assessment include incidence , severity , type adverse event throughout treatment ( 12 week ) , vital sign measurement ( pulse blood pressure ) laboratory test ( hematology , chemistry , urinalysis ) monthly interval . The study hypothesis treatment 12 week dapoxetine prolongs intravaginal ejaculatory latency time , compare placebo , men PE . Oral tablet dapoxetine ( 30 milligram [ mg ] 60mg ) take need 12 week treatment . No one dose within 24-hour period .</detailed_description>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>Heterosexual male stable , monogamous , sexual relationship female partner least 6 month onset orgasm ejaculation occur minimal sexual stimulation shortly penetration person wish premature ejaculation ( PE ) majority intercourse experience 6 month study initiation intravaginal latency ejaculatory time ( IELT ) &lt; =2 minute least 3 4 event participant partner childbearing potential must consent use medically acceptable method contraception throughout entire study participant 's partner must negative pregnancy test time screen . History surgery injury pelvis spinal cord , chronic inflammation prostate urethra take medication contraindicate participation study currently use form therapy treatment PE ( example , behavioral therapy medication apply locally ) previously participate drug study involve dapoxetine another drug trial within last month take pimozide , astemizole , monoamine oxidase inhibitor within 6 month start study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>dapoxetine</keyword>
	<keyword>rapid ejaculation</keyword>
	<keyword>premature ejaculation</keyword>
	<keyword>ejaculation</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>orgasmic disorder</keyword>
	<keyword>sexual intercourse</keyword>
</DOC>